RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization

K. Ito, Q. Liu, Manuel Salto-Tellez, T. Yano, K. Tada, H. Ida, C.H. Huang, N. Shah, M. Inoue, A. Rajnakova, K.C. Hiong, B.K. Peh, H.C. Han, T. Ito, M. Teh, K.G. Yeoh, Y. Ito

Research output: Contribution to journalArticlepeer-review

207 Citations (Scopus)


Loss of RUNX3 expression is suggested to be causally related to gastric cancer as 45% to 60% of gastric cancers do not express RUNX3 mainly due to hypermethylation of the RUNX3 promoter. Here, we examined for other defects in the properties of RUNX3 in gastric cancers that express RUNX3. Ninety-seven gastric cancer tumor specimens and 21 gastric cancer cell lines were examined by immunohistochemistry using novel anti-RUNX3 monoclonal antibodies. In normal gastric mucosa, RUNX3 was expressed most strongly in the nuclei of chief cells as well as in surface epithelial cells. In chief cells, a significant portion of the protein was also found in the cytoplasm. RUNX3 was not detectable in 43 of 97 (44%) cases of gastric cancers tested and a further 38% showed exclusive cytoplasmic localization, whereas only 18% showed nuclear localization. Evidence is presented suggesting that transforming growth factor-beta is an inducer of nuclear translocation of RUNX3, and RUNX3 in the cytoplasm of cancer cells is inactive as a tumor suppressor. RUNX3 was found to be inactive in 82% of gastric cancers through either gene silencing or protein mislocalization to the cytoplasm. In addition to the deregulation of mechanisms controlling gene expression, there would also seem to be at least one other mechanism controlling nuclear translocation of RUNX3 that is impaired frequently in gastric cancer.
Original languageEnglish
Pages (from-to)7743-7750
Number of pages8
JournalCancer Research
Issue number17
Publication statusPublished - 01 Sept 2005

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization'. Together they form a unique fingerprint.

Cite this